SEMA3A and chronic myelogenous leukemia, BCR-ABL1 positive: The expression of the secreted semaphorin SEMA3A was reported to be lower in acute lymphoid and myeloid leukemia (ALL/AML) and chronic myelogenous leukemia (CML) cells, compared to hematopoietic cells found in the normal BM (18).